These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25016105)

  • 1. Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunction.
    Mouri A; Hoshino Y; Narusawa S; Ikegami K; Mizoguchi H; Murata Y; Yoshimura T; Nabeshima T
    Psychoneuroendocrinology; 2014 Oct; 48():147-61. PubMed ID: 25016105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Monoaminergic System in Thyroid Hormone Receptor-β Deficient Mice as a Model of Attention-Deficit/Hyperactivity Disorder.
    Ookubo M; Sadamatsu M; Yoshimura A; Suzuki S; Kato N; Kojima H; Yamada N; Kanai H
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyv004. PubMed ID: 25612897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive.
    Siesser WB; Zhao J; Miller LR; Cheng SY; McDonald MP
    Genes Brain Behav; 2006 Apr; 5(3):282-97. PubMed ID: 16594981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.
    Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K
    Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice.
    Marians RC; Ng L; Blair HC; Unger P; Graves PN; Davies TF
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15776-81. PubMed ID: 12432094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse.
    Siesser WB; Cheng SY; McDonald MP
    Psychopharmacology (Berl); 2005 Oct; 181(4):653-63. PubMed ID: 15983791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
    Kasahara Y; Kubo Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Shibasaki Y; Hayata-Takano A; Hazama K; Nakazawa T; Shintani N; Kasai A; Nagayasu K; Hashimoto R; Tanida M; Katayama T; Matsuzaki S; Yamada K; Taniike M; Onaka Y; Ago Y; Waschek JA; Köves K; Reglődi D; Tamas A; Matsuda T; Baba A; Hashimoto H
    Neuroscience; 2015 Jun; 297():95-104. PubMed ID: 25841321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate normalizes emotional processing in adult patients with attention-deficit/hyperactivity disorder: preliminary findings.
    Conzelmann A; Woidich E; Mucha RF; Weyers P; Jacob CP; Lesch KP; Pauli P
    Brain Res; 2011 Mar; 1381():159-66. PubMed ID: 21215727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals.
    Vakalopoulos C
    Med Hypotheses; 2007; 68(1):210-21. PubMed ID: 16997497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.
    Marchant BK; Reimherr FW; Robison RJ; Olsen JL; Kondo DG
    J Atten Disord; 2011 May; 15(4):295-304. PubMed ID: 20410322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.
    Murray DW; Childress A; Giblin J; Williamson D; Armstrong R; Starr HL
    Clin Pediatr (Phila); 2011 Apr; 50(4):308-20. PubMed ID: 21436147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.